1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow DERMATOMYOSITIS OR POLYMYOSITIS: new trials by email Literature Review of DERMATOMYOSITIS OR POLYMYOSITIS trials Research Report on DERMATOMYOSITIS OR POLYMYOSITIS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) ULSC (1.5 x 10^8 cells/dose), Placebo (no cells) - Idiopathic Inflammatory Myositis (IIM), DERMATOMYOSITIS OR POLYMYOSITIS | Phase 2 / Phase 3 | Recruiting | Restem, LLC. | 40 | 2026-01-06 | 2026-04-27 |
| A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis MEDI-545, Placebo - DERMATOMYOSITIS OR POLYMYOSITIS | Phase 1 | Completed | MedImmune LLC | 51 | 2008-04-01 | 2012-05-28 |
Dermatomyositis (2) · Myositis (1)
Connective Tissue Diseases (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Polymyositis (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Myositis (1)
sifalimumab (1)
MedImmune LLC (1) · Restem, LLC. (1)
United States (2)
Dominique Ethgen, M.D. (1) · Michael Bubb, MD (1)